LENZ Therapeutics Inc (LENZ)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $129.77M
Last updated: Nov 17, 2026 at 11:05 AM ET
LENZ Therapeutics Inc (LENZ) Competitors
The companies most similar to LENZ Therapeutics are Zentalis Pharmaceuticals Llc (ZNTL), NRX Pharmaceuticals (NRXP) and Minerva Neurosciences (NERV). By market cap, LENZ Therapeutics ranks 6th of the 13 companies on this page; Bright Minds Biosciences (DRUG) is the largest at $227.96M.
Peer Comparison
LENZ's revenue growth of -72.9% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| LENZ Therapeutics (LENZ) | $129.77M | N/A | 9.7x | 0.0% | N/A | -72.9% | 0.00% |
| Zentalis Pharmaceuticals Llc (ZNTL) | $167.05M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| NRX Pharmaceuticals Inc (NRXP) | $95.58M | N/A | 23.8x | 0.0% | N/A | 0.0% | 0.00% |
| Minerva Neurosciences Inc (NERV) | $114.62M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tenaya Therapeutics Inc (TNYA) | $79.59M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Sionna Therapeutics, Inc. Common Stock (SION) | $150.63M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| NeOnc Technologies Holdings, Inc. Common Stock (NTHI) | $141.66M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Bright Minds Biosciences Inc (DRUG) | $227.96M | N/A | N/A | 0.0% | -11.2% | 0.0% | 0.00% |
| Zura Bio Limited Class A Ordinary Shares (ZURA) | $119.44M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tenax Therapeutics Inc (TENX) | $73.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| PolyPid (PYPD) | $132.25M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tiziana Life Sciences Ltd (TLSA) | $72.53M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Rein Therapeutics Inc (RNTX) | $47.63M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $117.03M | N/A | 23.8x | 0.0% | -11.2% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to LENZ Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Zentalis Pharmaceuticals Llc (ZNTL) | Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapies for the treatment... | ZNTL competitors |
| NRX Pharmaceuticals Inc (NRXP) | NRx Pharmaceuticals, Inc., a clinical-stage small molecule pharmaceutical company... | NRXP competitors |
| Minerva Neurosciences Inc (NERV) | Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of candidate products... | NERV competitors |
| Tenaya Therapeutics Inc (TNYA) | Tenaya Therapeutics Inc. is a pioneering clinical-stage biotechnology firm that is revolutionizing the treatment of heart disease through its proprietary... | TNYA competitors |
| Sionna Therapeutics, Inc. Common Stock (SION) | Sionna Therapeutics, Inc. is an innovative biotechnology company focused on developing advanced therapies for neurodegenerative disorders... | SION competitors |
| NeOnc Technologies Holdings, Inc. Common Stock (NTHI) | NeOnc Technologies Holdings, Inc. is a pioneering biotechnology firm dedicated to revolutionizing cancer treatment through its advanced immunotherapy... | NTHI competitors |
| Bright Minds Biosciences Inc (DRUG) | Bright Minds Biosciences Inc. (DRUG) is a forward-thinking clinical-stage biotechnology firm specializing in the development of groundbreaking therapies... | DRUG competitors |
| Zura Bio Limited Class A Ordinary Shares (ZURA) | Zura Bio Limited (Ticker: ZURA) is a biotechnology firm dedicated to developing breakthrough therapies for autoimmune disorders and rare diseases. | ZURA competitors |
| Tenax Therapeutics Inc (TENX) | Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing... | TENX competitors |
| PolyPid (PYPD) | PolyPid Ltd., an advanced stage biopharmaceutical company, develops, manufactures and markets products based on the Polymer Lipid Encapsulation Matrix (PLEX)... | PYPD competitors |
| Tiziana Life Sciences Ltd (TLSA) | Tiziana Life Sciences Plc, a clinical-stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat... | |
| Rein Therapeutics Inc (RNTX) | Rein Therapeutics Inc (RNTX) is a forward-thinking biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative disorders... | RNTX competitors |
Frequently Asked Questions About LENZ
Who are LENZ Therapeutics' main competitors?
The companies most similar to LENZ Therapeutics include Zentalis Pharmaceuticals Llc (ZNTL), NRX Pharmaceuticals (NRXP), Minerva Neurosciences (NERV), Tenaya Therapeutics (TNYA) and Sionna Therapeutics, Inc. Common Stock (SION), listed from the closest match.
Who is LENZ Therapeutics' biggest competitor?
Bright Minds Biosciences (DRUG) is the largest of the similar companies at $227.96M; Zentalis Pharmaceuticals Llc (ZNTL) is the closest match by business profile, size, sector and industry.
How does LENZ stock compare with its competitors?
LENZ's P/S is 9.7x against a peer median of 23.8x; its net margin is 0.0% against a peer median of 0.0%.
Which of LENZ Therapeutics' competitors pays a higher dividend?
LENZ Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is LENZ Therapeutics bigger than its competitors?
No. LENZ Therapeutics is 6th by market cap among the 13 companies on this page; the largest is Bright Minds Biosciences (DRUG) at $227.96M.
LENZ pages: Overview, Earnings, Forecast, Financials, Competitors